As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

AstraZeneca will now progress further CTA/IND-enabling studies and clinical development of the selected candidate, with Quell providing chemistry, manufacturing and controls (CMC) support including ...

With advancements in technology, researchers say people with diabetes can easily access health data and plan for the ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...